IL2 and graft versus host disease: As another component of immune cells, previous murine studies suggested that adoptive transfer of interleukin-2 (IL-2)-activated SCID NK cells with donor bone marrow cells promoted engraftment in allogenic hosts with no signs of GVHD (109).